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Letters to the Editor 
Dear Editor 
Amiodarone pneumonitis: no safe dose 
Polkey et al. (1) state that pulmonary toxicity with 
amiodarone is unusual at a maintenance dose below 
200mg day-‘. The following case report suggests 
that vigilance is required despite ‘low-dose amio- 
darone’ treatment. 
A 65year-old man presented with a 2-month 
history of progressive dyspnoea and dry cough. He 
had a history of paroxysmal atria1 fibrillation and 
had been commenced on amiodarone 18 months 
before. A loading dose of 600 mg daily for 7 days was 
followed by a maintenance dose of 100 mg daily. 
There was no history of myocardial infarction, heart 
failure, relevant occupational history nor exposure to 
avian antigen. On examination he was apyrexial. He 
was not clubbed and there was no lymphadenopathy. 
There were sparse inspiratory crackles at both bases. 
Routine haematology and biochemistry were un- 
remarkable and additional laboratory investigations 
were unhelpful. Serum amiodarone level was 0,2 mg 
1 - ’ (range 062.5) and desethylamiodarone level 
was 0.3 mg 1 - i (range 0.625). Lung function values 
were consistent with a severe restrictive defect, and a 
chest radiograph showed widespread alveolar and 
interstitial shadowing. An open lung biopsy showed 
diffuse interstitial pulmonary fibrosis involving both 
alveolar and interlobar septa. In several areas there 
were foci of fibrous and granulation tissue within the 
alveolar ducts and alveoli consistent with amiodarone- 
induced pulmonary toxicity. Amiodarone was with- 
drawn with improvement in radiological appearances 
and lung function and a return to normal values within 
6 months. 
Physicians should be aware that a life-threatening 
pneumonitis may occur even with doses below 
200mg day-‘. Every effort should be made to 
establish the lowest effective dose of amiodarone 
consistent with symptom and rhythm control. 
M. R. HARGREAVES AND M. K. BENSON 
Oxford RadclifSe Hospital NHS Trust 
Oxford, U.K. 
2 April 1995 
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Reply to Dr Hargreaves and Dr Benson 
I thank Dr Hargreaves and Dr Benson for their 
interest in our case. Their case is in many respects 
similar, as is the case recently described by Valle et al. 
(1). However, surely the lesson of these cases is not to 
use amiodarone in the lowest dose consistent with 
symptom and rhythm control which is, in any case, 
just good medical practice. Rather the question 
raised by these cases is whether greater emphasis 
should be placed on screening- for example, by 
spirometry or gas transfer measurements - users of 
low dose amiodarone. 
M. POLKEY 
King’s College School of Medicine & Dentistry 
London, U. K 
6 July 1995 
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Dear Editor 
Death in notified cases of tuberculosis in Edinburgh: 
1983-1992 
We read with interest the recent survey by Selby 
et al. (1) of the mortality from tuberculosis in 
Edinburgh. Their findings are in agreement with a 
similar study reported recently from Leeds (2). 
In a retrospective study, we reviewed all notifi- 
cations in the city (population 730 000) with tubercu- 
losis in the 5-yr period 19861990. The mortality data 
are summarized in Table 1. Of 375 confirmed notifi- 
cations, 53 (14%) patients died. Thirty-nine (10%) of 
these patients died from tuberculosis, with 26/37 
(67%) of deaths diagnosed at post mortem. Death 
from tuberculosis and diagnosis at post mortem was 
much more frequent in older subjects. Thirty-one 
(28%) subjects aged 65 years and older died from 
tuberculosis, compared with eight (3%) younger sub- 
jects (P<O.OOl by Chi-squared testing). Twenty-three 
(21%) elderly patients compared with three (1%) 
younger adults were diagnosed at post mortem 
(P<O.OOl by Chi-squared testing). 
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Table I Deaths in young and elderly subjects notified with tuberculosis in Leeds 19861990 
Young Elderly 
(age ~64 years) (age 265 years) Total 
Notifications 266 109 375 
Deaths 12 (5%) 41 (38%) 53 (14%) 
Deaths from tuberculosis 8 (3%) 31 (28%) 39 (10%) 
Post mortem notifications . 3 (1%) 23 (21%) 26 (7%) 
The mortality rate from tuberculosis in Leeds 
(10%) is higher than that reported in Edinburgh and 
other series, although the strong association be- 
tween mortality and age, and the fact that some 
two-thirds of those dying of tuberculosis were noti- 
fied after death, is similar in the two studies. The 
continuing high mortality and late diagnosis of tuber- 
culosis in the elderly is of major concern. In elderly 
subjects, a high index of suspicion is required if the 
unacceptably high mortality from tuberculosis is to 
be reduced. 
C.TEALE*,S. B.PEAR~~N~ AND J. M. GOLDMAN~ 
*Seacroft Hospital, Leeds 
tLeeds Chest Clinic and 
1 Torbay Hospital, U.K. 
31 May 1995 
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Dear Editor 
Spontaneous closure of a large emphysematous bulla 
We were interested to read the recent case report 
by Wahbi and Arnold (l), describing the rare occur- 
rence of spontaneous closure of a larger emphysema- 
tous bulla in a patient previously considered for 
surgical excision. We report a similar case in our 
hospital of a 74-year-old male smoker with known 
bilateral bullous emphysema (Plate 1) and long- 
standing disabling symptoms, who developed 
left-sided pleuritic pain and profound night sweats 
which persisted despite several courses of oral anti- 
biotics. Chest X-rays revealed fluid levels in the 
emphysematous bulla in the left upper lobe (Plate 2) 
and he was duly commenced on intravenous 
Plate I 
metronidazole, penicillin and gentamycin. Interest- 
ingly, Mantoux test was strongly positive,but sputum 
was negative for AAFB and TB culture. Following 2 
weeks of antibiotic therapy, there was significant 
clinical and radiological improvement. Oral anti- 
biotics were continued for a further 4 weeks, and at 
review 3 months later, chest X-ray showed that the 
infected bulla had contracted up to the left apex and 
that the’left lower lobe was now fully expanded. 
Dyspnoea improved and he remained asymptomatic 
at review 6 months later, when the very large bulla 
in the left upper lobe had completely disappeared 
(Plate 3). 
E. A. MILLAR AND P. D'A SEMPLE 
Department of General Medicine 
Inverclyde Royal Hospital 
Greenock, Scotland, U.K. 
19 June 1995 
